ACOX1
Basic information
Region (hg38): 17:75941507-75979177
Links
Phenotypes
GenCC
Source:
- Mitchell syndrome (Strong), mode of inheritance: AD
- peroxisomal acyl-CoA oxidase deficiency (Definitive), mode of inheritance: AR
- peroxisomal acyl-CoA oxidase deficiency (Strong), mode of inheritance: AR
- peroxisomal acyl-CoA oxidase deficiency (Supportive), mode of inheritance: AR
- Mitchell syndrome (Strong), mode of inheritance: AD
- peroxisomal acyl-CoA oxidase deficiency (Strong), mode of inheritance: AR
- Mitchell syndrome (Strong), mode of inheritance: AD
- peroxisomal acyl-CoA oxidase deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitchell syndrome | AD | Allergy/Immunology/Infectious | The condition has been described as manifesting with episodic demyelination, sensorimotor polyneuropathy, and hearing loss, and early diagnosis may allow medical management (eg, immunomodulatory and related treatments have been reported to show some clinical benefits in individuals) | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Biochemical; Craniofacial; Neurologic; Ophthalmologic | 2894756; 8040306; 8279468; 11815777; 17458872; 18536048; 32169171 |
ClinVar
This is a list of variants' phenotypes submitted to
- Acyl-CoA oxidase deficiency (25 variants)
- not provided (3 variants)
- Mitchell syndrome (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACOX1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 228 | 234 | ||||
missense | 151 | 162 | ||||
nonsense | 11 | 16 | ||||
start loss | 0 | |||||
frameshift | 13 | 12 | 26 | |||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 13 | 16 | ||||
splice region | 10 | 31 | 41 | |||
non coding | 108 | 122 | 46 | 276 | ||
Total | 27 | 35 | 260 | 354 | 55 |
Highest pathogenic variant AF is 0.0000131
Variants in ACOX1
This is a list of pathogenic ClinVar variants found in the ACOX1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-75941584-T-C | Acyl-CoA oxidase deficiency | Benign (Jan 13, 2018) | ||
17-75941614-T-C | Acyl-CoA oxidase deficiency | Likely benign (Jan 13, 2018) | ||
17-75941624-T-C | Acyl-CoA oxidase deficiency | Benign (Jan 13, 2018) | ||
17-75941631-T-G | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 13, 2018) | ||
17-75941656-T-C | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 13, 2018) | ||
17-75941711-A-G | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 12, 2018) | ||
17-75941720-A-C | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 13, 2018) | ||
17-75941748-C-A | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 13, 2018) | ||
17-75941872-G-A | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 13, 2018) | ||
17-75941915-CAT-C | Acyl-CoA oxidase deficiency | Uncertain significance (Jun 14, 2016) | ||
17-75941928-A-G | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 12, 2018) | ||
17-75941942-T-C | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 13, 2018) | ||
17-75941982-C-T | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 13, 2018) | ||
17-75942158-C-T | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 12, 2018) | ||
17-75942163-G-A | Acyl-CoA oxidase deficiency | Benign (Jan 13, 2018) | ||
17-75942169-G-A | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 12, 2018) | ||
17-75942197-G-A | Acyl-CoA oxidase deficiency | Likely benign (Jan 13, 2018) | ||
17-75942232-C-T | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 12, 2018) | ||
17-75942258-T-C | Acyl-CoA oxidase deficiency | Benign (Jan 12, 2018) | ||
17-75942259-G-A | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 13, 2018) | ||
17-75942264-T-C | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 12, 2018) | ||
17-75942275-C-CA | Acyl-CoA oxidase deficiency | Likely benign (Jun 14, 2016) | ||
17-75942304-C-T | Acyl-CoA oxidase deficiency | Benign (Jan 13, 2018) | ||
17-75942308-G-A | Acyl-CoA oxidase deficiency | Uncertain significance (Jun 14, 2016) | ||
17-75942361-C-G | Acyl-CoA oxidase deficiency | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACOX1 | protein_coding | protein_coding | ENST00000293217 | 14 | 37928 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0621 | 0.938 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.98 | 258 | 364 | 0.708 | 0.0000209 | 4363 |
Missense in Polyphen | 72 | 126.42 | 0.56954 | 1470 | ||
Synonymous | 0.225 | 132 | 135 | 0.975 | 0.00000817 | 1259 |
Loss of Function | 3.97 | 9 | 34.0 | 0.265 | 0.00000190 | 384 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000268 | 0.000268 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000132 | 0.000132 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the desaturation of acyl-CoAs to 2-trans- enoyl-CoAs. Isoform 1 shows highest activity against medium-chain fatty acyl-CoAs and activity decreases with increasing chain length. Isoform 2 is active against a much broader range of substrates and shows activity towards very long-chain acyl-CoAs. Isoform 2 is twice as active as isoform 1 against 16-hydroxy- palmitoyl-CoA and is 25% more active against 1,16-hexadecanodioyl- CoA. {ECO:0000269|PubMed:17458872, ECO:0000269|PubMed:17603022}.;
- Pathway
- Peroxisome - Homo sapiens (human);Biosynthesis of unsaturated fatty acids - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);alpha-Linolenic acid metabolism - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);Estrogen Receptor Pathway;Nuclear Receptors Meta-Pathway;PPAR signaling pathway;mechanism of gene regulation by peroxisome proliferators via ppara;Metabolism of lipids;alpha-linolenic acid (ALA) metabolism;Metabolism of proteins;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;Tyrosine metabolism;3-oxo-10R-octadecatrienoate beta-oxidation;Leukotriene metabolism;Omega-3 fatty acid metabolism;Saturated fatty acids beta-oxidation;Trihydroxycoprostanoyl-CoA beta-oxidation;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism;Peroxisomal protein import;Fatty acid metabolism;Mono-unsaturated fatty acid beta-oxidation;Omega-6 fatty acid metabolism;Bile acid biosynthesis;Di-unsaturated fatty acid beta-oxidation;Phytanic acid peroxisomal oxidation;Vitamin E metabolism;fatty acid β-oxidation (peroxisome);TYSND1 cleaves peroxisomal proteins
(Consensus)
Recessive Scores
- pRec
- 0.772
Intolerance Scores
- loftool
- 0.188
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63.57
Haploinsufficiency Scores
- pHI
- 0.160
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.525
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.994
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acox1
- Phenotype
- homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; reproductive system phenotype; immune system phenotype; liver/biliary system phenotype; neoplasm;
Gene ontology
- Biological process
- very long-chain fatty acid metabolic process;generation of precursor metabolites and energy;protein targeting to peroxisome;lipid metabolic process;prostaglandin metabolic process;spermatogenesis;regulation of lipid metabolic process;fatty acid oxidation;fatty acid beta-oxidation using acyl-CoA oxidase;alpha-linolenic acid metabolic process;lipid homeostasis
- Cellular component
- nucleus;nucleoplasm;nucleolus;peroxisome;peroxisomal membrane;peroxisomal matrix;cytosol;plasma membrane;membrane;intracellular membrane-bounded organelle
- Molecular function
- acyl-CoA oxidase activity;signaling receptor binding;fatty acid binding;palmitoyl-CoA oxidase activity;PDZ domain binding;protein N-terminus binding;flavin adenine dinucleotide binding;FAD binding